Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 18, 2022

SELL
$53.02 - $135.75 $180,161 - $461,278
-3,398 Reduced 95.37%
165 $9,000
Q3 2021

Oct 26, 2021

SELL
$55.56 - $60.79 $80,562 - $88,145
-1,450 Reduced 28.92%
3,563 $214,000
Q2 2021

Aug 13, 2021

BUY
$48.42 - $60.18 $242,729 - $301,682
5,013 New
5,013 $300,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Karp Capital Management Corp Portfolio

Follow Karp Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Karp Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Karp Capital Management Corp with notifications on news.